Paul Bunn
Net worth: 257 131 $ as of 2026-07-30
Net worth: 257 131 $ as of 2026-07-30
Paul A. Bunn was the founder of ApopLogic Pharmaceuticals, Inc., founded in 2006, where the title held was Director & Founding Scientist.
Current jobs include Independent Director at Verastem, Inc. since 2021 and Professor at The University of Colorado School of Medicine.
Former jobs include President, Chief Executive Officer & Director at the International Association for the Study of Lung Cancer; President & Director at the American Society of Clinical Oncology, Inc.; Director at the University of Colorado Cancer Center; Head-Medical Oncology at The University of Colorado; and President at the Association of American Cancer Institutes.
Education includes undergraduate studies at Amherst College and a doctorate from Weill Cornell Medical College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VERASTEM, INC. 0.07% | 2026-05-20 | 44,333 ( 0.07% ) | 257 131 $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| VERASTEM, INC. | Director/Board Member | 2021-06-23 |
The University of Colorado School of Medicine
The University of Colorado School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
International Association for the Study of Lung Cancer
International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a multidisciplinary organization dedicated to the study, research, and eradication of lung cancer and other thoracic malignancies. The non-profit company is based in Aurora, CO. It serves a diverse community including oncologists, thoracic specialists, scientists, patient advocates, and caregivers, advancing lung cancer care through collaborative science, education, advocacy, and clinical practice. IASLC organizes major conferences, supports scientific projects, develops resources for targeted therapy, and publishes journals focused on thoracic oncology. The organization fosters professional development, provides educational materials, policy toolkits, patient advocacy initiatives, and training workshops to improve lung cancer diagnosis, treatment, and prevention. | Chief Executive Officer | - |
Association of American Cancer Institutes
Association of American Cancer Institutes Miscellaneous Commercial ServicesCommercial Services Operates as a membership association and cancer research center | President | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | President | - |
University of Colorado Cancer Center
University of Colorado Cancer Center Other Consumer ServicesConsumer Services Functions as a College/University | Director/Board Member | - |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 10 |
|---|---|
ApopLogic Pharmaceuticals, Inc.
ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Amherst College
Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
International Association for the Study of Lung Cancer
International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a multidisciplinary organization dedicated to the study, research, and eradication of lung cancer and other thoracic malignancies. The non-profit company is based in Aurora, CO. It serves a diverse community including oncologists, thoracic specialists, scientists, patient advocates, and caregivers, advancing lung cancer care through collaborative science, education, advocacy, and clinical practice. IASLC organizes major conferences, supports scientific projects, develops resources for targeted therapy, and publishes journals focused on thoracic oncology. The organization fosters professional development, provides educational materials, policy toolkits, patient advocacy initiatives, and training workshops to improve lung cancer diagnosis, treatment, and prevention. | Commercial Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of American Cancer Institutes
Association of American Cancer Institutes Miscellaneous Commercial ServicesCommercial Services Operates as a membership association and cancer research center | Commercial Services |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
The University of Colorado School of Medicine
The University of Colorado School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Colorado Cancer Center
University of Colorado Cancer Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions